Global Human Milk Oligosaccharides (HMO) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Human Milk Oligosaccharides (HMO) market size will reach 1,164.38 Million USD in 2025 and is projected to reach 6,069.19 Million USD by 2032, with a CAGR of 26.60% (2025-2032). Notably, the China Human Milk Oligosaccharides (HMO) market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Human Milk Oligosaccharides (HMOs) are a complex group of naturally occurring carbohydrates found in human breast milk. These compounds are the third most abundant solid component in breast milk after lactose and lipids. HMOs serve essential functions in supporting the health and development of infants. While infants cannot directly digest HMOs, they act as prebiotics, promoting the growth and activity of beneficial bacteria in the infant＇s gut, particularly Bifidobacteria. This prebiotic effect contributes to the development of a healthy gut microbiome, which, in turn, plays a crucial role in immune system development and overall well-being. HMOs also have antimicrobial properties, preventing the attachment of harmful pathogens to the intestinal lining. Research suggests that HMOs may offer various health benefits, including immune system support, protection against infections, and positive effects on cognitive development. Due to their potential health-promoting properties, HMOs have become an area of interest in infant formula research as scientists seek to mimic the composition of breast milk for formula-fed infants.

The major global  manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Human Milk Oligosaccharides (HMO). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Human Milk Oligosaccharides (HMO) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Human Milk Oligosaccharides (HMO) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Milk Oligosaccharides (HMO) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Human Milk Oligosaccharides (HMO) Include:

Abbott

Inbiose

Glycom

Chr. Hansen (Jennewein)

Elicityl SA

ZuChem

Human Milk Oligosaccharides (HMO) Product Segment Include:

2＇-FL & 3-FL

LNT & LNnT, etc.

Human Milk Oligosaccharides (HMO) Product Application Include:

Infant Formula

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Human Milk Oligosaccharides (HMO) Industry PESTEL Analysis

Chapter 3: Global Human Milk Oligosaccharides (HMO) Industry Porter's Five Forces Analysis

Chapter 4: Global Human Milk Oligosaccharides (HMO) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 5: Global Human Milk Oligosaccharides (HMO) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 6: Global Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Forecast by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 8: Industrial Chain Analysis, Human Milk Oligosaccharides (HMO) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources Show more